Showing results (1-10 of 139) with videos related to
Sort By:
Pageof 14
Methods in Molecular Biology (Clifton, N.J.)|March 16, 2004
RNA interference (RNAi) with RNase III-prepared siRNAsDun Yang, Andrei Goga, J Michael BishopNature Medicine|June 26, 2007
Inhibition of CDK1 as a potential therapy for tumors over-expressing MYCAndrei Goga, Dun Yang, Aaron D Tward, et al.Proceedings of the National Academy of Sciences of the United States of America|July 21, 2010
Therapeutic potential of a synthetic lethal interaction between the MYC proto-oncogene and inhibition of aurora-B kinaseDun Yang, Hong Liu, Andrei Goga, et al.Proceedings of the National Academy of Sciences of the United States of America|July 4, 2002
Short RNA duplexes produced by hydrolysis with Escherichia coli RNase III mediate effective RNA interference in mammalian cellsDun Yang, Frank Buchholz, Zhongdong Huang, et al.Proceedings of the National Academy of Sciences of the United States of America|October 13, 2004
Cell division and cell survival in the absence of survivinDun Yang, Alana Welm, J Michael BishopMolecular Interventions|September 11, 2007
Anti-oncomir suppression of tumor phenotypesAndrei Goga, Christopher BenzAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Taking on challenging targets: making MYC druggableDai Horiuchi, Brittany Anderton, Andrei GogaFrontiers in Cell and Developmental Biology|April 27, 2017
In vivo Reprogramming of Cancer Metabolism by MYCRoman Camarda, Jeremy Williams, Andrei GogaNature Cell Biology|May 15, 2012
MYC suppresses cancer metastasis by direct transcriptional silencing of αv and β3 integrin subunitsHong Liu, Derek C Radisky, Dun Yang, et al.Micropublication Biology|April 25, 2024
Changes in spindle morphology driven by TPX2 overexpression in MYC-driven breast cancer cellsGuadalupe Pena, Julia Rohrberg, Andrei Goga, et al.Pageof 14